HAMILTON, ON, August 18, 2021 / – Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global telemedicine company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, today announced that, in response to customer demand, it has expanded its proprietary iUGO Care platform to support Medicare-funded Remote Patient Monitoring (RPM), Chronic Care Management (CCM) and Behavioural Health Integration (BHI) services provide by clinicians treating HIV patients.

“There are over 1.2 Million people in the US currently living with HIV,”said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “Roughly 80% of these patients are under age 65 but qualify for Medicare due to disability, and since all individuals over age 65 are covered by Medicare the vast majority of individuals living with HIV qualify for Medicare-funded virtual care services delivered using the iUGO Care platform. People living with HIV are more likely to experience early onset of age-related illnesses such as cardiovascular disease, diabetes and kidney disease, and tend to be more severely affected than their age-matched counterparts who do not have HIV. A large percentage of these patients do not have primary care physicians but instead rely on specialized HIV clinics for all of their healthcare. Historically these clinics have been underfunded and understaffed, which led to requests from clinic staff to have Reliq expand our iUGO Care platform to enable them to better serve HIV patients through virtual care. The expansion to our platform allows clinicians to leverage Medicare-funded virtual care programs like Remote Patient Monitoring, Chronic Care Management and Behavioural Health Integration to provide high quality, proactive care to HIV patients while generating new revenue streams for their clinics. The average HIV clinic will receive an additional $372 USD per patient per month by deploying iUGO Care, while improving health outcomes and quality of life for HIV patients. Reliq expects to begin onboarding HIV patients this fall, at an average revenue of $65 USD per patient per month for the Company.” 

Reliq Health

Reliq Health Technologies is a rapidly growing global telemedicine that specializes in developing innovative Virtual Care solutions for the multi-billion dollar Healthcare market. Reliq’s powerful iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery.  iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits.  Reliq Health Technologies trades on the TSX Venture under the symbol RHT, on the OTC as RQHTF and on the WKN as A2AJTB. 


“Dr. Lisa Crossley”

CEO and Director

For further information please contact:

Company Contact

Investor Relations at ir@reliqhealth.com

US Investor Relations Contact

Investor Relations
Lytham Partners, LLC
Ben Shamsian
New York | Phoenix


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. 

Cautionary Statements Regarding Forward Looking Information

Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws.  All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements”. 

We caution you that such “forward-looking statements” involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements. 

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.  

Reliq Health Technologies Inc. (the “Company“) does not intend and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company’s historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements. 

SOURCE: Reliq Health Technologies Inc.